Corporate Sponsorsview all sponsors
MSHO continuously contacts legislators, provides comments to policy makers and collaborates with payers on issues of concern to those delivering care to cancer patients.
It is important that our members are aware of meetings, web casts, and other educational opportunities specifically designed to address the complexities of cancer care.
Pfizer Brings Three New Biosimilars to U.S. Patients at Substantial Discounts
(Pfizer) Jan 23, 2020 - Pfizer will become the first company to bring three oncology monoclonal antibody (mAb) biosimilar treatments to the U.S. market. Read Corporate Press Release